Purchase Order 75N92020P00096

This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Research and Diagnostic Systems, Inc. is valued at $445,214.70 to deliver 89 items including 27 types of recombinant human proteins and 12 small molecule compounds by June 30, 2021. As the sole source provider, Research and Diagnostic Systems will ship the products from its Minneapolis location within 14 days of each order to support the Center's consistent research...

This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Research And Diagnostic Systems, Inc. (R&D Systems), a subsidiary of the parent company Bio-Techne Corporation. The $9,991.10 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call order that provides a range of biological research materials, laboratory supplies, and scientific instruments to support biomedical research. R&D...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Meso Scale Diagnostics LLC for $148,989.10 on August 16, 2021, for procurement of a custom U-PLEX biomarker set. The awardee is a Native American-owned small business. Work is performed at the awardee's location in Bethesda, Maryland. The order, funded under the Coronavirus COVID-19 National Interest Action, has an ultimate completion date of November 1, 2021, and is priced on a firm fixed price basis.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Technical Manufacturing Corp for $16,461.00 on March 5, 2020. The order is for specialized laboratory and research equipment, with place of performance in Peabody, Massachusetts. Ultimate completion is scheduled for July 18, 2020. The award was issued on firm fixed-price basis without a set-aside designation, though it originated from a total small business set-aside solicitation posted February 21, 2020.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,250.50 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&amp;D Systems, a division of Bio-Techne Corporation. The contract is for research and development reagents to be delivered from October 17, 2023 through November 6, 2023. As the prime contractor, R&amp;D Systems will provide laboratory supplies and materials to support the NIH Clinical Center's...

<p>The National Institute on Aging awarded a purchase order to Research and Diagnostic Systems, Inc. for custom array service on June 1, 2020, with a ceiling value of $10,200.00 and an ultimate completion date of July 10, 2020. Work is performed in Minneapolis, Minnesota. No set-aside category was used; this was an open competition purchase order using firm fixed price terms.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Cerba Research USA, Inc. valued at $112,198 on July 31, 2018, to procure serum biomarker assay services. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of July 30, 2019. No small business set-aside applied to this procurement.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Werfen USA LLC for a platelet reactivity testing system valued at $25,343.81 on March 10, 2021, with completion on April 10, 2021. The order is firm fixed price with no set-aside. Work is performed in Bedford, Massachusetts, where Werfen manufactures in vitro diagnostic equipment and clinical laboratory instrumentation.</p>

The National Heart Lung and Blood Institute awarded a purchase order to Inova Diagnostics, Inc. for $14,719.80 on February 9, 2021, with completion by March 9, 2021. The order is firm fixed price with no set-aside designation. Performance takes place in San Diego, California. The procurement supplies diagnostic kits for COVID-19 convalescent plasma testing to support patient treatment with recovered patient plasma. The kits are required for urgent laboratory experiments affecting immediate...